Given the link established across studies between marketing practices and the opioid overdose crisis, a few strategic steps can form a path forward for clinicians and policymakers.
2024 presents an exciting yet challenging landscape for global pharma marketers. Prioritizing digital transformation, adopting patient-centric strategies, navigating regulatory complexities, investing in innovative content marketing, and fostering global collaboration position pharmaceutical marketers to make a lasting impact in an ever-evolving industry.
The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.
Healthcare brands should always build their own digital marketing strategy from scratch - rather than using a blueprint from another successful digital industry.
With emerging biotech needing help with a little bit of everything, these preferred partnerships can deliver a type of one-stop shopping leveraging an agency’s best practices, current trends, and data.
Interactive, cloud-based video games are designed to tackle pharma's current challenge: engaging doctors virtually during a pandemic. But the tools are likely to outlive the circumstances in which they were born.
The healthcare and pharmaceutical industries are people-centered by design. So how did tech companies become the default “brands that care”?
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.